Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
TLK286 in Combination With Paraplatin (Carboplatin) in Recurrent Ovarian Cancer (NCT00051948)Telik2003-01-01
Schizotypal Personality Disorder Risperidone (NCT02535156)Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau2003-01-01
An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer (NCT00054899)Epimmune2003-01-01
Does B Vitamin Supplementation Decrease Homocysteine Concentrations in Newborns (NCT00877227)Radboud University Medical Center2003-01-01
Pharmacokinetic (PK) Study of Twice Daily vs Once Daily Lamivudine (3TC) and Abacavir (ABC) as Part of Combination Antiretroviral Therapy (ART) in HIV Infected Children (NCT01982396)PENTA Foundation2003-01-01
Yoga for Treating Shortness of Breath in Chronic Obstructive Pulmonary Disease (COPD) (NCT00051792)National Center for Complementary and Integrative Health (NCCIH)2003-01-01
Blockade of Vascular Potassium Channels During Human Endotoxemia (NCT00185003)Radboud University Medical Center2003-01-01
CPG 7909 in Patients With Cutaneous T-Cell Lymphoma (NCT00043420)Pfizer2003-01-01
A Study to Assess the Systemic Pharmacokinetics, Metabolism and Excretion Routes of YM178 in Man, After Administration of Radio-labeled YM178 (NCT01651312)Astellas Pharma Europe B.V.2003-01-01
Post-Operative Chemoradiation for Extremity & Trunk Soft Tissue Sarcoma (NCT00502411)M.D. Anderson Cancer Center2003-01-01
Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune Diseases (NCT00849745)Duke University2003-01-01
Fasting Study of Loxapine Succinate Capsules 25 mg and Loxitane® Capsules 25 mg (NCT00648778)Mylan Pharmaceuticals Inc2003-01-01
Bioequivalence Study of Lamotrigine 25 mg Chewable Tablets of Dr.Reddy's Under Fasting Condition (NCT01131949)Dr. Reddy's Laboratories Limited2003-01-01
Safety Study to Explore Combination of Gefitinib (ZD1839, Iressa) and Radiotherapy in Non-Metastatic Prostate Cancer (NCT00239291)AstraZeneca2003-01-01
Radiofrequency Ablation of Tumors (NCT00705497)St. Jude Children's Research Hospital2003-01-01
Study of Radiation Dose Intensity Concurrent With Chemotherapy For Limited Stage Small Cell Lung Cancer (NCT00126828)AHS Cancer Control Alberta2003-01-01
Evaluation of Adhesion Quality and Irritation of an Alternate Second Generation Estradiol Transdermal System (NCT00650442)Mylan Pharmaceuticals Inc2003-01-01
Study With Rituximab-Gemcitabine/Oxaliplatin in Relapsed Indolent Lymphoma (NCT00954005)German Low Grade Lymphoma Study Group2003-01-01
The Efficacy of Reiki in the Treatment of Fibromyalgia (NCT00051428)National Center for Complementary and Integrative Health (NCCIH)2003-01-01
Vaccine Therapy For Patients Being Considered For Organ Transplant Who Are at Risk For PTLD (NCT00278200)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2003-01-01
Neurotomy of Optic Nerve in Non-Arthritic Anterior Ischemic Optic Neuropathy (NCT00372021)Shahid Beheshti University of Medical Sciences2003-01-01
Study of Intralesional Injection of M4N in Patients With Refractory Malignant Tumors of the Head and Neck (NCT00057512)Erimos Pharmaceuticals2003-01-01
Effect of Exercise on Prevention of Weight Gain (NCT00177502)University of Pittsburgh2003-01-01
Pilot Safety Trial of Chemotherapy and Use of Heparin in Patients With Pancreatic Cancer (NCT01945879)CONKO-Studiengruppe2003-01-01
Ghrelin Decreases Insulin Sensitivity (NCT00512525)University of Aarhus2003-01-01
Food Study of Metoprolol Tartrate/Hydrochlorothiazide Tablets 100/50 mg to Lopressor HCT® Tablets 100/50 mg (NCT00649233)Mylan Pharmaceuticals Inc2003-01-01
rhEndostatin Protein Involving Pediatric Patients With Cancer (NCT00165373)Dana-Farber Cancer Institute2003-01-01
Glucose Clamp Study to Prove Hypo- and Hyperglycemic Episodes Using a Non-invasive Glucose Monitoring Device (NCT01060917)Profil Institut für Stoffwechselforschung GmbH2003-01-01
Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF (NCT00952237)Dartmouth-Hitchcock Medical Center2003-01-01
Depression Treatment and Screening in Ovarian Cancer Patients (NCT00515372)M.D. Anderson Cancer Center2002-12-20
Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate Cancer (NCT00054106)NCIC Clinical Trials Group2002-12-10
Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP) (NCT00117143)Amgen2002-12-02
CellCept in p-ANCA Vasculitis (NCT00405860)Mayo Clinic2002-12-01
The Safety and Dose Response to Single Anal Doses of NRL001 (NCT06593743)Norgine2002-12-01
Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas (NCT00053937)National Cancer Institute (NCI)2002-12-01
Cocaethylene as a Treatment for Cocaine Dependence - 1 (NCT00124696)National Institute on Drug Abuse (NIDA)2002-12-01
Food Study of Oxybutynin Chloride Extended-release Tablets 5 mg and Ditropan XL® Tablets 5 mg (NCT00648843)Mylan Pharmaceuticals Inc2002-12-01
Pyrazoloacridine and Stem Cell or Bone Marrow Transplantation in Treating Young Patients With High-Risk Neuroblastoma (NCT00053950)National Cancer Institute (NCI)2002-12-01
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Healthy Japanese Volunteers (NCT01620463)Novo Nordisk A/S2002-12-01
Phase I/II Dose Escalation Study of VELCADE® and Docetaxel in Patients With Advanced Androgen-Independent Prostate Cancer (NCT00064610)Millennium Pharmaceuticals, Inc.2002-12-01
Food Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mg (NCT00648856)Mylan Pharmaceuticals Inc2002-12-01
Study of ABT-751 in Patients With Refractory Hematologic Malignancies (NCT00047489)M.D. Anderson Cancer Center2002-12-01
Venlafaxine 25 mg Tablets Under Non-Fasting Conditions (NCT00834249)Teva Pharmaceuticals USA2002-12-01
Safety and Efficacy of BAY 50-4798 in Patients With HIV Infection (NCT00059462)Bayer2002-12-01
Study of Xeloda and Gleevec in Patients With Advanced Solid Tumors (NCT00183833)University of Southern California2002-12-01
Mental Health Services for Foster and Adopted Children (NCT00056303)University of Delaware2002-12-01
GW786034 in Treating Patients With Advanced Solid Tumors (NCT00060151)Case Comprehensive Cancer Center2002-12-01
Brostallicin in Treating Patients With Recurrent or Refractory Multiple Myeloma (NCT00060203)Case Comprehensive Cancer Center2002-12-01
TK-based Suicide Gene Therapy for Hepatocellular Carcinoma (NCT00844623)Clinica Universidad de Navarra, Universidad de Navarra2002-12-01
Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme (NCT00050986)M.D. Anderson Cancer Center2002-12-01
Fasting Study of Metolazone Tablets 2.5 mg and Zaroloxyn® Tablets 2.5 mg (NCT00649051)Mylan Pharmaceuticals Inc2002-12-01
Monoclonal Antibody Vaccine Therapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer (NCT00058435)Memorial Sloan Kettering Cancer Center2002-12-01
Prevention of Type 2 Diabetes Mellitus in Children (NCT00073268)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2002-12-01
VEGF Gene Transfer for Diabetic Neuropathy (NCT00056290)Losordo, Douglas, M.D.2002-12-01
Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fasting Condition (NCT01513720)Dr. Reddy's Laboratories Limited2002-12-01
Regeneration of Human Intrabony Defects With rhFGF-2/HA (NCT02337166)Universidade Federal Fluminense2002-12-01
Fed Study of Metoprolol Tartrate Tablets 100 mg and Lopressor® 100 mg (NCT00649116)Mylan Pharmaceuticals Inc2002-12-01
Nicotinic Modulation of Schizophrenia-like Information Processing Deficits in Healthy Subjects (NCT00690170)Yale University2002-12-01
Suramin and Paclitaxel in Treating Women With Stage IIIB-IV Breast Cancer (NCT00054028)National Cancer Institute (NCI)2002-12-01
SGN-00101 in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia (NCT00052897)National Cancer Institute (NCI)2002-12-01
Bioequivalence Study of Pravastatin Sodium Tablets 80 mg Under Fasting Conditions (NCT01146106)Dr. Reddy's Laboratories Limited2002-12-01
Fasting Study of Hydromorphone Hydrochloride 8 mg Tablets and Dilaudid 8 mg Tablets (NCT00853554)Mallinckrodt2002-12-01
PH 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel/ Carboplatin As 1st Line Chemotherapy In NSCLC Patients (NCT00174356)Pfizer2002-12-01
Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Repeated Dose Transdermal Rotigotine in Japanese and Caucasian Subjects (NCT01854216)UCB BIOSCIENCES GmbH2002-12-01
Study of Nesiritide in Diastolic Heart Failure. (NCT00309868)Massachusetts General Hospital2002-12-01
A Phase I/II Study to Assess the Safety and Efficacy of Vaccinations With Allogeneic Dendritic Cells: Autologous Tumor-Derived Cells Subjected to Electrofusions in Patients With AJCC Stage IV Renal Cell Carcinoma (NCT00625755)Beth Israel Deaconess Medical Center2002-12-01
Treatment of Chronic Lymphocytic B-Leukemia With IL-2 and CD-40 Autologous Tumor Cells (NCT00058786)Baylor College of Medicine2002-12-01
Trial of Paroxetine-CR for the Treatment of Patients With Post Traumatic Stress Disorder Remaining Symptomatic After Initial Exposure Therapy (NCT00121888)Massachusetts General Hospital2002-12-01
Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia (NCT00401089)London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2002-12-01
Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Solid Tumors (NCT00389584)University of California, Davis2002-12-01
HIV Prevention in Haitian American Adolescents (NCT00494273)Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2002-12-01
Venlafaxine 25 mg Tablets Under Fasting Conditions (NCT00834964)Teva Pharmaceuticals USA2002-12-01
Fasting Study of Oxybutynin Chloride Extended-release Tablets 5 mg and Ditropan XL® Tablets 5 mg (NCT00650481)Mylan Pharmaceuticals Inc2002-12-01
Fed Study of Metoprolol Tartrate Tablets 25 mg and Lopressor® 50 mg (NCT00648271)Mylan Pharmaceuticals Inc2002-12-01
LY317615 Plus Capecitabine in Treating Patients With Advanced Solid Tumors (NCT00052273)Jonsson Comprehensive Cancer Center2002-12-01
Interleukin-12 and Interleukin-2 in Treating Patients With Refractory or Recurrent Neuroblastoma (NCT00054405)National Cancer Institute (NCI)2002-12-01
Fed Study of Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Lotensin HCT® Tablets 20 mg/25 mg (NCT00649038)Mylan Pharmaceuticals Inc2002-12-01
Ondansetron HCl Orally Disintegrating Tablets Under Fasting Conditions (NCT00934180)Teva Pharmaceuticals USA2002-12-01
A Randomized, Double-Blind, Placebo-Controlled Trial of Simvastatin on Subarachnoid Hemorrhage-Induced Vasospasm (NCT00235963)Brigham and Women's Hospital2002-12-01
Decitabine in Treating Children With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia (NCT00042796)National Cancer Institute (NCI)2002-12-01
Effect of BIBT 986 Followed by BIBT 986 Given as IV Infusion on Tissue Factor Triggered Coagulation in Healthy Male Volunteers (NCT02259881)Boehringer Ingelheim2002-12-01
Phase I Dose Escalation Study of VELCADE Plus Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors (NCT00064636)Millennium Pharmaceuticals, Inc.2002-12-01
Phase I/II Study of CAMPATH in Patients With Relapsing or Refractory Non-Hodgkin's Lymphoma (NCT00051701)Genzyme, a Sanofi Company2002-12-01
Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Breast Cancer (NCT00854789)COL George Peoples, MD, FACS2002-12-01
Fasting Study of Quinapril Hydrochloride Tablets 40 mg and Accupril® Tablets 40 mg (NCT00649103)Mylan Pharmaceuticals Inc2002-12-01
Food Study of Quinapril Hydrochloride Tablets 40 mg and Accupril® Tablets 40 mg (NCT00649649)Mylan Pharmaceuticals Inc2002-12-01
Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis (NCT00685568)M.D. Anderson Cancer Center2002-11-21
Preliminary Study of Transcranial Magnetic Stimulation for Stroke Rehabilitation (NCT00050128)National Institute of Neurological Disorders and Stroke (NINDS)2002-11-18
Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Japanese Subjects (NCT01527630)Novo Nordisk A/S2002-11-16
Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors (NCT01275222)Novartis Pharmaceuticals2002-11-13
Phase I Study of HeFi-1 to Treat Cancers With CD30 Protein (NCT00048880)National Cancer Institute (NCI)2002-11-05
Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Male Subjects (NCT01527552)Novo Nordisk A/S2002-11-05
A Dose Linearity Study of the Labopharm Formulation of Tramadol HCl/Contramid®, 100 mg, 200 mg and 300 mg After A Single Oral Administration In Fasting Condition, In Healthy Human Volunteers (NCT00834808)Labopharm Inc.2002-11-01
Cognitive-Behavioral Treatment of Gambling (NCT00118391)UConn Health2002-11-01
Study of Lonafarnib and Gleevec in Chronic Myelogenous Leukemia (NCT00047502)M.D. Anderson Cancer Center2002-11-01
First In Human, Phase 1 Study of AG013736 In Patients With Solid Tumors (NCT01469052)Pfizer2002-11-01
Cognitive Behavioral Therapy for the Treatment of Seasonal Affective Disorder (SAD) (NCT00076245)Henry M. Jackson Foundation for the Advancement of Military Medicine2002-11-01
BIBR 953 ZW in Healthy Elderly Subjects (NCT02173730)Boehringer Ingelheim2002-11-01
Safety and Efficacy Study of Ex Vivo Immunotherapy for Treatment of Aplastic Anemia (NCT00399971)Shenzhen Zhongxing Yangfan Biotech Co. Ltd.2002-11-01
A Pharmacokinetic Evaluation Study in Healthy Volunteers (NCT00210054)Merck Sharp & Dohme LLC2002-11-01
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.